Business Context and Reporting Period
Company: The Scotts Miracle-Gro Company (SMG)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended June 28, 2025 (Fiscal Q3 2025) and nine months ended June 28, 2025.
Business Overview: SMG manufactures and markets lawn and garden care products (U.S. Consumer and Other segments) and indoor/hydroponic gardening products (Hawthorne segment). The business is highly seasonal, with over 75% of annual net sales occurring in the second and third fiscal quarters.
Key Financial Metrics
| Metric (in millions) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $1,188.0 | $1,202.2 | $3,025.8 | $3,138.0 |
| Gross Margin | $378.0 (31.8%) | $354.1 (29.5%) | $1,020.7 (33.7%) | $880.0 (28.0%) |
| Income from Operations | $215.0 | $200.1 | $508.7 | $424.9 |
| Net Income | $149.1 | $132.1 | $297.1 | $209.1 |
| Diluted EPS | $2.54 | $2.28 | $5.07 | $3.64 |
| Operating Cash Flow (9M) | $197.2 | $549.0 | $197.2 | $549.0 |
| Total Debt | $2,202.6 | $2,507.2 | $2,202.6 | $2,507.2 |
| Cash & Equivalents | $51.1 | $279.9 | $51.1 | $279.9 |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 1.2% in Q3 and 3.6% for the nine months ended June 28, 2025, compared to the prior year. The decline was driven by lower volume in the Hawthorne segment (due to cannabis oversupply) and the discontinuation of third-party product sales, partially offset by higher volume in U.S. Consumer soils and grass seed.
- Profitability: Despite lower sales, Net Income increased 12.9% in Q3 and 42.1% for the nine months. This was primarily driven by a significant expansion in gross margin rates (up 2.3% in Q3 and 5.7% for 9M) due to lower material costs and favorable product mix, alongside reduced interest expense.
- Restructuring: Total impairment, restructuring, and other charges were $6.1 million in Q3 2025 and $45.8 million for the nine months, a significant decrease from $60.8 million in the prior nine-month period. The prior year included substantial inventory write-downs and facility closure costs in the Hawthorne segment.
- Cash Flow: Operating cash flow for the nine months dropped significantly to $197.2 million from $549.0 million, attributed to higher inventory production, timing of accounts receivable sales, and higher incentive compensation payments.
Guidance, Outlook, and Risks
- Outlook: Management expects the oversupply of cannabis to continue adversely impacting the Hawthorne segment. The company is monitoring macroeconomic conditions, including inflation and interest rates, and potential trade policy changes.
- Liquidity & Debt Covenants:
- Total indebtedness is $2,187.5 million. The company does not have sufficient cash on hand to repay all debt in the event of a default.
- Leverage Ratio: 4.15x (within the 5.00x covenant limit for Q3 2025).
- Fixed Charge Coverage: 1.47x (above the 1.00x minimum).
- Interest Coverage: 4.52x (above the 2.00x minimum).
- Contingency Planning: Management has contemplated alternative plans for potential covenant non-compliance, including further restructuring, cash management strategies, lender discussions, or equity issuance. There is no assurance these plans will be successful.
- Legal Proceedings: The company is defending against securities litigation alleging misstatements regarding inventories and sales, as well as asbestos-related claims. Management believes these claims are without merit and not expected to have a material adverse effect.
Investor Verification Checklist
- Hawthorne Segment Trajectory: Verify the duration and severity of the cannabis oversupply impact on the Hawthorne segment, which saw a 53.9% sales decline in Q3.
- Debt Covenant Compliance: Monitor the leverage ratio closely as it approaches the 4.75x limit in Q4 2025 and 4.50x in Q1 2026, given the company's admission of insufficient liquidity to repay debt in a default scenario.
- Operating Cash Flow Volatility: Assess the sustainability of operating cash flows given the sharp year-over-year decline and the heavy reliance on accounts receivable sales programs.
- Restructuring Completion: Confirm the final costs and timeline for the ongoing restructuring initiatives, particularly regarding inventory reduction in the Hawthorne segment.
- Legal Exposure: Track developments in the consolidated securities litigation and asbestos claims to ensure no material accruals are required.